Abattis Bioceuticals Corp.
ATTBF · OTC
9/30/2019 | 9/30/2018 | 9/30/2017 | 9/30/2016 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3 | -$78 | -$8 | -$2 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | -$1 | $17 | $1 | -$0 |
| Stock-Based Comp. | $0 | $0 | $1 | $0 |
| Change in WC | $8 | -$1 | $0 | $0 |
| Other Non-Cash | $5 | $52 | $6 | $1 |
| Operating Cash Flow | $9 | -$8 | -$1 | -$1 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$0 | -$0 | -$0 |
| Net Acquisitions | -$10 | -$16 | $0 | $0 |
| Inv. Purchases | $5 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $3 | $0 | $0 | $0 |
| Other Inv. Act. | -$5 | $0 | -$0 | $0 |
| Investing Cash Flow | -$12 | -$16 | -$0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $28 | $2 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $28 | $2 | $1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2 | $4 | $0 | -$0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4 | $1 | $0 | $0 |
| End Cash | $2 | $4 | $1 | $0 |
| Free Cash Flow | $4 | -$9 | -$2 | -$1 |